RecruitingNCT07380412

A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications

A short description of this study’s research objective has not yet been verified.

Placebo comparisonAges 18–55United StatesADHD

The study in practice

Understand this study

Listed age limits: 18 years to 55 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: August 12, 2025

Recruitment status: Recruiting
Enrollment listed in the registry: 90
Sponsor: Outliers, Inc.
Sponsor type: Other organization
Study type: Other
Intervention type: DIETARY_SUPPLEMENT
Study phase: Not clearly listed
Locations: United States
Age range: From 18 Years to 55 Years
Official registry ID: NCT07380412
Official title: A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications

Study ID: NCT07380412. We help you review the study, but cannot decide medical eligibility.

Recruiting

Las Vegas

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Outliers, Inc.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.